These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 37781369)
1. Case Report: ASCENIV use in three young children with immune abnormalities and acute respiratory failure secondary to RSV infection. Bindernagel C; Sotoudeh S; Nguyen M; Wetzstein G; Sriaroon P; Walter J Front Immunol; 2023; 14():1154448. PubMed ID: 37781369 [TBL] [Abstract][Full Text] [Related]
2. Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group. Rodriguez WJ; Gruber WC; Welliver RC; Groothuis JR; Simoes EA; Meissner HC; Hemming VG; Hall CB; Lepow ML; Rosas AJ; Robertsen C; Kramer AA Pediatrics; 1997 Mar; 99(3):454-61. PubMed ID: 9041304 [TBL] [Abstract][Full Text] [Related]
3. Compassionate use experience with high-titer respiratory syncytical virus (RSV) immunoglobulin in RSV-infected immunocompromised persons. Falsey AR; Koval C; DeVincenzo JP; Walsh EE Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28054734 [TBL] [Abstract][Full Text] [Related]
4. WITHDRAWN: Immunoglobulin treatment for respiratory syncytial virus infection. Fuller HL; Del Mar CB Cochrane Database Syst Rev; 2010 Sep; 2010(9):CD004883. PubMed ID: 20824840 [TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin treatment for respiratory syncytial virus infection. Fuller H; Del Mar C Cochrane Database Syst Rev; 2006 Oct; (4):CD004883. PubMed ID: 17054220 [TBL] [Abstract][Full Text] [Related]
7. Efficacy, Safety, and Pharmacokinetics of a New 10 % Liquid Intravenous Immunoglobulin Containing High Titer Neutralizing Antibody to RSV and Other Respiratory Viruses in Subjects with Primary Immunodeficiency Disease. Wasserman RL; Lumry W; Harris J; Levy R; Stein M; Forbes L; Cunningham-Rundles C; Melamed I; Kobayashi AL; Du W; Kobayashi R J Clin Immunol; 2016 Aug; 36(6):590-9. PubMed ID: 27324887 [TBL] [Abstract][Full Text] [Related]
13. Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease. The Cardiac Study Group. Simoes EA; Sondheimer HM; Top FH; Meissner HC; Welliver RC; Kramer AA; Groothuis JR J Pediatr; 1998 Oct; 133(4):492-9. PubMed ID: 9787686 [TBL] [Abstract][Full Text] [Related]
14. RI-002, an intravenous immunoglobulin containing high titer neutralizing antibody to RSV and other respiratory viruses for use in primary immunodeficiency disease and other immune compromised populations. Wasserman RL; Greener BN; Mond J Expert Rev Clin Immunol; 2017 Dec; 13(12):1107-1119. PubMed ID: 29035131 [TBL] [Abstract][Full Text] [Related]
15. Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage. Romero JR Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S46-54. PubMed ID: 12671452 [TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes in outpatient respiratory syncytial virus infection in immunocompromised children. Chu HY; Chin J; Pollard J; Zerr DM; Englund JA Influenza Other Respir Viruses; 2016 May; 10(3):205-10. PubMed ID: 26859306 [TBL] [Abstract][Full Text] [Related]
17. Respiratory Syncytial Virus is the Most Common Causative Agent of Viral Bronchiolitis in Young Children: An Updated Review. Hon KL; Leung AKC; Wong AHC; Dudi A; Leung KKY Curr Pediatr Rev; 2023; 19(2):139-149. PubMed ID: 35950255 [TBL] [Abstract][Full Text] [Related]
18. Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis. Jacque E; Chottin C; Laubreton D; Nogre M; Ferret C; de Marcos S; Baptista L; Drajac C; Mondon P; De Romeuf C; Rameix-Welti MA; Eléouët JF; Chtourou S; Riffault S; Perret G; Descamps D Front Immunol; 2021; 12():683902. PubMed ID: 34163482 [TBL] [Abstract][Full Text] [Related]
19. The burden of respiratory syncytial virus infections among children with sickle cell disease. Rostad CA; Maillis AN; Lai K; Bakshi N; Jerris RC; Lane PA; Yee ME; Yildirim I Pediatr Blood Cancer; 2021 Jan; 68(1):e28759. PubMed ID: 33034160 [TBL] [Abstract][Full Text] [Related]